Introducing Less Invasive Ventricular Enhancement (LIVE®)

  • Remodel Heart Failure
  • Regain Function
  • Renew Life

About Us

 

BioVentrix, Inc. is a clinical stage medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies. BioVentrix technologies aim to improve cardiac function by directly addressing LV dilation.

The BioVentrix Revivent™ System is designed to support a minimally invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy. The procedure uses myocardial micro-anchor implants to reconstruct the dilated left ventricle to produce a more efficient chamber.

Our Management Team

Our Board of Directors

  • David Richmond – Founding Partner and Chairman, Richmond Brothers, Inc.
  • Steven Chartier – President & Co-CEO, BioVentrix, Inc.
  • Mike Taglich – Taglich Brothers Investment Banking